Cas no 1261475-16-4 (1-Bromo-3-isocyanato-2-methylbenzene)

1-Bromo-3-isocyanato-2-methylbenzene is a versatile aromatic compound featuring both bromo and isocyanato functional groups on a methyl-substituted benzene ring. This structure makes it a valuable intermediate in organic synthesis, particularly for the preparation of pharmaceuticals, agrochemicals, and specialty polymers. The bromo substituent allows for further functionalization via cross-coupling reactions, while the isocyanato group enables participation in urethane or urea formation, expanding its utility in polymer chemistry. Its well-defined reactivity profile and stability under controlled conditions make it suitable for precise synthetic applications. Careful handling is required due to the isocyanato group's sensitivity to moisture and potential irritancy.
1-Bromo-3-isocyanato-2-methylbenzene structure
1261475-16-4 structure
Product Name:1-Bromo-3-isocyanato-2-methylbenzene
CAS No:1261475-16-4
MF:C8H6BrNO
MW:212.043341159821
MDL:MFCD18392235
CID:2115828
PubChem ID:65542331
Update Time:2025-05-24

1-Bromo-3-isocyanato-2-methylbenzene Chemical and Physical Properties

Names and Identifiers

    • 1-?bromo-?3-?isocyanato-?2-?methylBenzene
    • 1-bromo-3-isocyanato-2-methylbenzene
    • 1-Bromo-3-isocyanato-2-methyl-benzene
    • PSXWSKMUMKTPLF-UHFFFAOYSA-N
    • 9767AH
    • NE63618
    • 1-Bromo-3-isocyanato-2-methylbenzene
    • MDL: MFCD18392235
    • Inchi: 1S/C8H6BrNO/c1-6-7(9)3-2-4-8(6)10-5-11/h2-4H,1H3
    • InChI Key: PSXWSKMUMKTPLF-UHFFFAOYSA-N
    • SMILES: BrC1=CC=CC(=C1C)N=C=O

Computed Properties

  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 1
  • Complexity: 177
  • Topological Polar Surface Area: 29.4

1-Bromo-3-isocyanato-2-methylbenzene Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
B702983-10mg
1-Bromo-3-isocyanato-2-methylbenzene
1261475-16-4
10mg
$ 50.00 2022-06-06
TRC
B702983-50mg
1-Bromo-3-isocyanato-2-methylbenzene
1261475-16-4
50mg
$ 135.00 2022-06-06
TRC
B702983-100mg
1-Bromo-3-isocyanato-2-methylbenzene
1261475-16-4
100mg
$ 210.00 2022-06-06
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
03R0306-1g
1-Bromo-3-isocyanato-2-methyl-benzene
1261475-16-4 96%
1g
831.08CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
03R0306-5g
1-Bromo-3-isocyanato-2-methyl-benzene
1261475-16-4 96%
5g
3375.21CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
03R0306-25g
1-Bromo-3-isocyanato-2-methyl-benzene
1261475-16-4 96%
25g
13483.87CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
03R0306-500mg
1-Bromo-3-isocyanato-2-methyl-benzene
1261475-16-4 96%
500mg
746.28CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
03R0306-250mg
1-Bromo-3-isocyanato-2-methyl-benzene
1261475-16-4 96%
250mg
644.51CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
03R0306-100mg
1-Bromo-3-isocyanato-2-methyl-benzene
1261475-16-4 96%
100mg
576.67CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-YP895-5g
1-Bromo-3-isocyanato-2-methylbenzene
1261475-16-4 96%
5g
2089.0CNY 2021-07-15

Additional information on 1-Bromo-3-isocyanato-2-methylbenzene

Recent Advances in the Application of 1-Bromo-3-isocyanato-2-methylbenzene (CAS: 1261475-16-4) in Chemical Biology and Pharmaceutical Research

1-Bromo-3-isocyanato-2-methylbenzene (CAS: 1261475-16-4) is a versatile chemical intermediate that has garnered significant attention in recent chemical biology and pharmaceutical research. This compound, characterized by its reactive isocyanate and bromo functional groups, serves as a critical building block in the synthesis of various biologically active molecules. Recent studies have highlighted its utility in the development of novel therapeutics, particularly in the areas of targeted drug delivery and covalent inhibitor design.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 1-Bromo-3-isocyanato-2-methylbenzene as a key intermediate in the synthesis of covalent kinase inhibitors. The researchers utilized its isocyanate group to form stable urea linkages with lysine residues in the ATP-binding pocket of target kinases, resulting in highly selective and potent inhibitors. The bromo substituent further allowed for subsequent functionalization via cross-coupling reactions, enabling the introduction of diverse pharmacophores to optimize drug-like properties.

In the field of chemical biology, this compound has been employed as a versatile scaffold for the development of activity-based probes (ABPs). A recent ACS Chemical Biology publication (2024) described its use in creating fluorescent probes for serine hydrolases. The reactive isocyanate group selectively labels active site serines, while the bromo group serves as an attachment point for fluorophores, enabling real-time monitoring of enzyme activity in complex biological systems.

From a synthetic chemistry perspective, 1-Bromo-3-isocyanato-2-methylbenzene has shown remarkable utility in parallel synthesis approaches. Its dual functionality allows for sequential modification through both nucleophilic addition to the isocyanate and metal-catalyzed cross-coupling reactions at the bromo position. This characteristic has been particularly valuable in combinatorial chemistry and high-throughput screening campaigns for drug discovery.

Recent safety and handling studies have provided updated guidelines for working with this compound. While highly useful, the isocyanate group presents potential respiratory sensitization hazards, requiring proper engineering controls and personal protective equipment. The bromo substituent also necessitates careful consideration of waste disposal regulations. These practical considerations have been addressed in recent Good Manufacturing Practice (GMP) guidelines for pharmaceutical production.

Looking forward, the unique properties of 1-Bromo-3-isocyanato-2-methylbenzene position it as a valuable tool in emerging areas such as PROTAC (Proteolysis Targeting Chimera) development and covalent fragment-based drug discovery. Its ability to serve as a bifunctional linker between target-binding moieties and E3 ligase recruiters in PROTACs is particularly promising, as evidenced by several recent patent applications in this area.

Recommended suppliers
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shenzhen Yaoyuan R&D Center Co.,Ltd
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Handan Zechi Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk